Clinical Trials Logo

Clinical Trial Summary

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of human papillomavirus (HPV) infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.


Clinical Trial Description

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men. ;


Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00799474
Study type Observational
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase N/A
Start date December 2008
Completion date January 2009

See also
  Status Clinical Trial Phase
Completed NCT01717391 - [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Phase 2
Completed NCT00622440 - Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream Phase 2
Active, not recruiting NCT03018418 - Proton Therapy in Reducing Toxicity in Anal Cancer Phase 2
Enrolling by invitation NCT02526953 - Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients Phase 3
Recruiting NCT05578820 - Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid Phase 1
Recruiting NCT02384005 - The Feasibility of Self or Partner-assisted Digital Anal Exam Screening N/A
Completed NCT00428285 - Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men Phase 2
Completed NCT00107679 - A Study of Anal Cancer Development in HIV Infected People N/A
Terminated NCT01408407 - Alkagin Paste in the Prevention of Radiation Dermatitis Phase 2
Completed NCT03202992 - Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection Phase 1
Completed NCT00000764 - Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. Phase 1